We are live on ! Find out more
AIM icon

AIM ImmunoTech

41 hedge funds and large institutions have $6.86M invested in AIM ImmunoTech in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

19% more capital inflows, than outflows

Capital inflows: $1.29M | Capital outflows: $1.08M

14% more funds holding

Funds holding: 36 → 41 (+5)

0.34% more ownership

Funds ownership: 15.26% → 15.6% (+0.34%)

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

Holders
41
Holders Change
+5
Holders Change %
+13.89%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

AIM Hedge Fund Activity: Q4 2021 in Review

41 of the 6,523 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q4 2021, worth a combined $6.86M — down 53% from $14.7M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new AIM positions and 4 closed out — a net gain of 5 holders — while 6 added to existing stakes and 10 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $1.09M. The largest seller was Morgan Stanley, cutting an estimated $531K.

  • 41 institutional investors held AIM ImmunoTech (AIM) as of Q4 2021, up from 36 in Q3 2021.
  • Funds reported $6.86M of AIM ImmunoTech stock for Q4 2021, down 53% quarter-over-quarter.
  • 9 funds opened new AIM ImmunoTech positions in Q4 2021 and 4 closed out, a net change of +5 holders.
  • The largest AIM ImmunoTech buyer in Q4 2021 was Renaissance Technologies, an estimated $1.09M added.
  • The largest AIM ImmunoTech seller in Q4 2021 was Morgan Stanley, an estimated $531K sold.

Based on aggregated 13F filings for Q4 2021.